1. Home
  2. VALN vs DAKT Comparison

VALN vs DAKT Comparison

Compare VALN & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • DAKT
  • Stock Information
  • Founded
  • VALN 2012
  • DAKT 1968
  • Country
  • VALN France
  • DAKT United States
  • Employees
  • VALN N/A
  • DAKT N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • DAKT Office Equipment/Supplies/Services
  • Sector
  • VALN Health Care
  • DAKT Industrials
  • Exchange
  • VALN Nasdaq
  • DAKT Nasdaq
  • Market Cap
  • VALN 777.9M
  • DAKT 710.0M
  • IPO Year
  • VALN 2021
  • DAKT 1994
  • Fundamental
  • Price
  • VALN $10.71
  • DAKT $19.23
  • Analyst Decision
  • VALN Strong Buy
  • DAKT Strong Buy
  • Analyst Count
  • VALN 4
  • DAKT 1
  • Target Price
  • VALN $15.75
  • DAKT $26.00
  • AVG Volume (30 Days)
  • VALN 78.1K
  • DAKT 820.8K
  • Earning Date
  • VALN 11-06-2025
  • DAKT 09-10-2025
  • Dividend Yield
  • VALN N/A
  • DAKT N/A
  • EPS Growth
  • VALN N/A
  • DAKT 9.66
  • EPS
  • VALN N/A
  • DAKT 0.23
  • Revenue
  • VALN $230,566,060.00
  • DAKT $749,361,000.00
  • Revenue This Year
  • VALN $15.69
  • DAKT $12.94
  • Revenue Next Year
  • VALN $22.15
  • DAKT $7.16
  • P/E Ratio
  • VALN N/A
  • DAKT $82.97
  • Revenue Growth
  • VALN 25.47
  • DAKT N/A
  • 52 Week Low
  • VALN $3.62
  • DAKT $10.24
  • 52 Week High
  • VALN $12.25
  • DAKT $24.38
  • Technical
  • Relative Strength Index (RSI)
  • VALN 53.86
  • DAKT 41.02
  • Support Level
  • VALN $9.70
  • DAKT $20.59
  • Resistance Level
  • VALN $12.23
  • DAKT $21.22
  • Average True Range (ATR)
  • VALN 0.44
  • DAKT 0.62
  • MACD
  • VALN 0.04
  • DAKT -0.46
  • Stochastic Oscillator
  • VALN 34.78
  • DAKT 2.67

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: